Akelos, Inc. funding

Akelos, Inc., a biotechnology company based in New York, NY, filed a Form D with the SEC on March 16, 2026 and reported $1.5M raised.

Amount raised$1.5M

Offering sizeOpen-ended

Filed with the SECMarch 16, 2026

First saleMarch 9, 2026

IndustryBiotechnology

SecuritiesEquity, Debt, Options or warrants

LocationNew York, NY

FoundedMore than 5 years ago

Entity typeCorporation

Investors so far81

Minimum investment$13.8K

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Mar 16

Other health care rounds in New York

Precision Neuroscience Corp$250M · Sep 28Other Health Care Click Therapeutics, Inc.$50M · Oct 1Other Health Care Amani Therapeutics, Inc.$35M · Oct 1Other Health Care Atmos Clinic, Inc.$6M · Oct 8Other Health Care CAD Therapeutics, Inc.$4M · Oct 2Biotechnology PreciseDx, Inc.$3.7M · Oct 7Other Health Care Hypercell Technologies Inc.$3M · Oct 14Biotechnology AmorSui Inc.$2.7M · Sep 23Other Health Care